Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McDonagh, J. E.
Right arrow Articles by Walker, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDonagh, J. E.
Right arrow Articles by Walker, D. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 322-327, Copyright © 1997 by British Society for Rheumatology

ORIGINAL PAPERS

Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees

JE McDonagh, A Dunn, WE Ollier and DJ Walker
Bloomsbury Rheumatology Unit, Middlesex Hospital, London.

The objective was to explore the role of HLA-DRB1 genes in determining disease severity in rheumatoid arthritis (RA). The population comprised extended pedigrees of 17 multicase RA families. Family members were genotyped for both HLA-DRB1 alleles using restriction fragment length polymorphism (RFLP). Identification of HLA-DRB1*04 variants was performed using the Multiplex ARMS-RFLP technique. Compound heterozygote individuals carrying two different alleles containing the shared epitope (SE) were at greatest risk of developing RA (odds ratio = 36, 95% CI 9.1-143). A synergistic or additive effect of these alleles is suggested. Individuals carrying no SE alleles expressed milder disease, as measured by the Spread Severity (SS) index, compared to compound heterozygotes (P = 0.045). Compound heterozygosity was not invariably associated with severe disease with six (50%) having clinically mild disease at a median age of 57.5 yr and median disease duration of 16 yr. Inheriting two different SE-bearing alleles results in an increased risk of RA and, on average, greater disease severity. This is not, however, invariably associated with severe disease, making it of limited use as a predictor of prognosis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
S. Laivoranta-Nyman, T. Möttönen, R. Luukkainen, M. Hakala, U. Yli-Kerttula, P. Hannonen, J. Tuokko, A. Toivanen, and J. Ilonen
Immunogenetic differencies between patients with familial and non-familial rheumatoid arthritis
Ann Rheum Dis, March 1, 2000; 59(3): 173 - 177.
[Abstract] [Full Text]

Home page
 Rheumatology (Oxford)Home page
D. L. Mattey, A. B. Hassell, M. J. Plant, N. T. Cheung, P. T. Dawes, P. W. Jones, W. Thomson, K. V. Poulton, A. H. Hajeer, and W. E. R. Ollier
The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis
Rheumatology, December 1, 1999; 38(12): 1221 - 1227.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.